claim: zydus cadila begins human trials of its potential vaccine for coronavirus
evidence_1: zydus had earlier this month announced that its plasmid dna vaccine candidate (zycov-d) developed at its vaccine technology centre in ahmedabad, india had successfully completed the preclinical phase and had received permission from the drug controller general of india (dcgi) permission to initiate adaptive phase i/ii human clinical trials in india.", "trade watchlist portfolio message set alert live bselive nselive volume todays l/h more × zydus cadila, on july 15 said that it has begun giving its potential coronavirus (covid-19) vaccine to healthy volunteers in the first and second phases of human clinical trials across multiple sites."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )